We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
1626
AMC Global Media
AMCX
$490M
$37K ﹤0.01%
704
-1,223
-63% -$63.5K
BGS icon
1627
B&G Foods
BGS
$278M
$37K ﹤0.01%
+848
New +$37.7K
BHE icon
1628
Benchmark Electronics
BHE
$2.96B
$37K ﹤0.01%
+1,196
New +$32.7K
FCNCA icon
1629
First Citizens BancShares
FCNCA
$25.5B
$37K ﹤0.01%
103
-253
-71% -$82.6K
GNL icon
1630
Global Net Lease
GNL
$1.91B
$37K ﹤0.01%
1,586
+1,201
+312% +$27.5K
KEP icon
1631
Korea Electric Power
KEP
$16B
$37K ﹤0.01%
1,986
+1,694
+580% +$35.3K
HAPN
1632
Happen Inc
HAPN
$2.27B
$37K ﹤0.01%
1,391
+885
+175% +$24.3K
NEOG icon
1633
Neogen
NEOG
$2.46B
$37K ﹤0.01%
+1,515
New +$33.6K
PFS icon
1634
Provident Financial Services
PFS
$3.23B
$37K ﹤0.01%
+1,322
New +$32.9K
PTC icon
1635
PTC
PTC
$16B
$37K ﹤0.01%
800
-842
-51% -$39.4K
QLYS icon
1636
Qualys
QLYS
$6.29B
$37K ﹤0.01%
+1,177
New +$41.4K
REGN icon
1637
Regeneron Pharmaceuticals
REGN
$79.5B
$37K ﹤0.01%
100
+99
+9,900% +$37.6K
SXI icon
1638
Standex International
SXI
$4.09B
$37K ﹤0.01%
+418
New +$36.5K
SYBT icon
1639
Stock Yards Bancorp
SYBT
$2.61B
$37K ﹤0.01%
+791
New +$31.1K
CMBT
1640
CMB.TECH NV
CMBT
$4.76B
$37K ﹤0.01%
4,690
-4,328
-48% -$32.9K
LL
1641
DELISTED
LL Flooring Holdings, Inc.
LL
$37K ﹤0.01%
2,337
+2,311
+8,888% +$40.2K
IBA
1642
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$37K ﹤0.01%
761
-3,525
-82% -$175K
XOG
1643
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$37K ﹤0.01%
+1,824
New +$38.8K
GNMK
1644
DELISTED
GenMark Diagnostics, Inc
GNMK
$37K ﹤0.01%
3,026
+1,547
+105% +$18.4K
GEN
1645
DELISTED
Genesis Healthcare, Inc.
GEN
$37K ﹤0.01%
8,706
+7,637
+714% +$25.2K
MEET
1646
DELISTED
The Meet Group, Inc. Common Stock
MEET
$37K ﹤0.01%
7,509
-12,701
-63% -$65.6K
PLKI
1647
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$37K ﹤0.01%
+608
New +$34.8K
CY
1648
DELISTED
Cypress Semiconductor
CY
$37K ﹤0.01%
3,194
-6,776
-68% -$74.3K
CATO icon
1649
Cato Corp
CATO
$65.9M
$36K ﹤0.01%
+1,212
New +$37.3K
DOX icon
1650
Amdocs
DOX
$6.28B
$36K ﹤0.01%
+611
New +$36K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.